As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Wellness Genomics Market: By Type: Predictive Testing, Consumer Genomics, Others; By Setting Type: DTC, Professional; By Application: Breast and Ovarian Cancer Screening, Others; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Wellness Genomics Market Outlook

The global wellness genomics market attained a value of USD 4 billion in 2020. The wellness genomics market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 14% to reach USD 8.8 billion by 2026.

 

The increased awareness of healthcare and the changing preferences of the population for a healthier lifestyle have contributed to the growth of the wellness genomics industry.

 

Global Wellness Genomics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Genomics or genome sequencing had been previously synonymous with the threat of a disease or more death. With genome sequencing becoming cheaper and more affordable, numerous bioinformatics companies offer services that use DNA-based information to treat ageing, manage or detect wellness, or even the sports a person must pursue in accordance with genetic information, and eventually attempt to combine a healthy approach to his life. Genetic data can be used for a substantially healthy life. This is now referred to as wellness genomics.

 

Global Wellness Genomics Market By Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on type, the wellness genomics market can be divided into predictive testing and consumer genomics.

Predictive testing can be further divided into:

  • Genetic Susceptibility Test
  • Predictive Diagnostics
  • Population Screening Programs

Consumer genomics is further segmented into:

  • Wellness Genetics
  • Nutria Genetics
  • Skin and Metabolism Genetics
  • Others

The setting type is divided into the following:

  • DTC
  • Professional

The wellness genomics market can be broadly categorised based on its applications into:

  • Breast and Ovarian Cancer Screening
  • Cardiovascular Screening
  • Diabetic Screening and Monitoring
  • Colon Cancer Screening
  • Alzheimer’s Disease
  • Prostate Cancer Screening
  • Orthopaedic and Musculoskeletal Screening
  • Other Cancer Screening
  • Other Diseases Screening

The EMR report looks into the regional wellness genomics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Wellness Genomics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

 

Market Analysis

The increased awareness of healthcare and the changing population preferences to a healthy lifestyle contributed to the growth of the predictive genetics research and the wellness genomics industry. The global genetic testing and wellness genomics market are expected to be driven by factors such as increased public and private regulatory attention to public health, improved genetic test efficacy and efficiency, the prevalence of genetically modified chronic diseases, and diseases such as Parkinson’s and cystic fibroids. In addition, the growing need to comprehend one’s family history also drives the global market. Strict regulatory regulations and ethics to allow genetic testing could, however, restrict the market growth.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global wellness genomics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories (NYSE: ABT)
  • Thermo Fisher Scientific, Inc. 
  • Agilent Technologies, Inc. 
  • Bio-Rad Laboratories, Inc. 
  • Illumina, Inc. 
  • Qiagen NV 
  • Myriad Genetics, Inc. 
  • Siemens AG 
  • Cooper Surgical, Inc. 
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Setting Type, Application, Region
Breakup by Type Predictive Testing, Consumer Genomics, Others
Breakup by Setting Type DTC, Professional
Breakup by Application Breast and Ovarian Cancer Screening, Cardiovascular Screening, Diabetic Screening & Monitoring, Colon Cancer Screening, Alzheimer’s Disease, Prostate Cancer Screening, Orthopaedic and Musculoskeletal Screening, Other Cancer Screening, Other Diseases Screening
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered F. Hoffmann-La Roche Ltd. (SWX: ROG), Abbott Laboratories (NYSE: ABT), Thermo Fisher Scientific, Inc. (NYSE: TMO), Agilent Technologies, Inc. (NYSE: A), Bio-Rad Laboratories, Inc. (NYSE: BIO), Illumina, Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Wellness Genomics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Wellness Genomics Historical Market (2016-2020) 
    8.3    Global Wellness Genomics Market Forecast (2021-2026)
    8.4    Global Wellness Genomics Market by Type
        8.4.1    Predictive Testing
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Consumer Genomics
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Others
    8.5    Global Wellness Genomics Market by Setting Type
        8.5.1    DTC
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Professional
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
    8.6    Global Wellness Genomics Market by Application
        8.6.1    Breast and Ovarian Cancer Screening
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Cardiovascular Screening
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Diabetic Screening and Monitoring
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
        8.6.4    Colon Cancer Screening
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2016-2020)
            8.6.4.3    Forecast Trend (2021-2026)
        8.6.5    Alzheimer’s Disease
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2016-2020)
            8.6.5.3    Forecast Trend (2021-2026)
        8.6.6    Prostate Cancer Screening
            8.6.6.1    Market Share
            8.6.6.2    Historical Trend (2016-2020)
            8.6.6.3    Forecast Trend (2021-2026)
        8.6.7    Orthopedic and Musculoskeletal Screening
            8.6.7.1    Market Share
            8.6.7.2    Historical Trend (2016-2020)
            8.6.7.3    Forecast Trend (2021-2026)
        8.6.8    Other Cancer Screening 
        8.6.9    Other Diseases Screening 
    8.7    Global Wellness Genomics Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    F. Hoffmann-La Roche Ltd.
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Abbott Laboratories
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Thermo Fisher Scientific, Inc.
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Agilent Technologies, Inc.
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Bio-Rad Laboratories, Inc.
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Illumina, Inc.
            11.2.6.1    Company Overview
            11.2.6.2    Product Portfolio
            11.2.6.3    Demographic Reach and Achievements
            11.2.6.4    Certifications
        11.2.7    Others
12    Industry Events and Developments


List of Figures and Tables

1.    Global Wellness Genomics Market: Key Industry Highlights, 2016 and 2026
2.    Global Wellness Genomics Historical Market: Breakup by Type (USD Million), 2016-2020
3.    Global Wellness Genomics Market Forecast: Breakup by Type (USD Million), 2021-2026
4.    Global Wellness Genomics Historical Market: Breakup by Setting Type (USD Million), 2016-2020
5.    Global Wellness Genomics Market Forecast: Breakup by Setting Type (USD Million), 2021-2026
6.    Global Wellness Genomics Historical Market: Breakup by Application (USD Million), 2016-2020
7.    Global Wellness Genomics Market Forecast: Breakup by Application (USD Million), 2021-2026
8.    Global Wellness Genomics Historical Market: Breakup by Region (USD Million), 2016-2020
9.    Global Wellness Genomics Market Forecast: Breakup by Region (USD Million), 2021-2026
10.    North America Global Wellness Genomics Historical Market: Breakup by Country (USD Million), 2016-2020
11.    North America Global Wellness Genomics Market Forecast: Breakup by Country (USD Million), 2021-2026
12.    Europe Global Wellness Genomics Historical Market: Breakup by Country (USD Million), 2016-2020
13.    Europe Global Wellness Genomics Market Forecast: Breakup by Country (USD Million), 2021-2026
14.    Asia Pacific Global Wellness Genomics Historical Market: Breakup by Country (USD Million), 2016-2020
15.    Asia Pacific Global Wellness Genomics Market Forecast: Breakup by Country (USD Million), 2021-2026
16.    Latin America Global Wellness Genomics Historical Market: Breakup by Country (USD Million), 2016-2020
17.    Latin America Global Wellness Genomics Market Forecast: Breakup by Country (USD Million), 2021-2026
18.    Middle East and Africa Global Wellness Genomics Historical Market: Breakup by Country (USD Million), 2016-2020
19.    Middle East and Africa Global Wellness Genomics Market Forecast: Breakup by Country (USD Million), 2021-2026
20.    Global Wellness Genomics Market Structure

Key Questions Answered in the Report

In 2020, the global wellness genomics market attained a value of nearly USD 4 billion.

The market is projected to grow at a CAGR of 14% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach about USD 8.8 billion by 2026.

The major drivers of the industry, such as the increased awareness of healthcare, changing population preferences to a healthy lifestyle, increased public and private regulatory attention to public health, improved genetic test efficacy and efficiency, and the prevalence of genetically modified chronic diseases and diseases such as Parkinson’s and cystic fibroids, are expected to aid the market growth.

The key market trend guiding the growth of the market includes the growing awareness regarding the comprehension of one’s family history.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading types of wellness genomics in the industry include predictive testing and consumer genomics.

The major setting types within the industry are DTC and professional.

The significant applications in the industry are breast and ovarian cancer screening, cardiovascular screening, diabetic screening and monitoring, colon cancer screening, Alzheimer’s disease, prostate cancer screening, orthopaedic and musculoskeletal screening, other cancer screening, and other diseases screening.

The major players in the industry are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., Qiagen NV, Myriad Genetics, Inc., Siemens AG, and Cooper Surgical, Inc., among others.

Analyst Review

The global wellness genomics market attained a value of USD 4 billion in 2020, driven by the rising awareness of healthcare. Aided by the changing lifestyles to a healthier one, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 14%. The market is projected to reach USD 8.8 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the wellness genomics industry can be segmented into predictive testing and consumer genomics. On the basis of setting types, the industry is bifurcated into DTC and professional.  On the basis of applications, the industry is divided into breast and ovarian cancer screening, cardiovascular screening, diabetic screening and monitoring, colon cancer screening, Alzheimer’s disease, prostate cancer screening, orthopaedic and musculoskeletal screening, other cancer screening, and other diseases screening. The major regional markets for wellness genomics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., Qiagen NV, Myriad Genetics, Inc., Siemens AG, Cooper Surgical, Inc., and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER